TRP_1170x120_12-19-19

Renvela (sevelamer carbonate) for oral suspension

Dr. Reddy’s launches sevelamer carbonate for oral suspension in U.S.

Dr. Reddy’s launches sevelamer carbonate for oral suspension in U.S.

PRINCETON, N.J. — Dr. Reddy’s Laboratories announced the launch of sevelamer carbonate for oral suspension, in 0.8 g and 2.4 g packets, a therapeutic equivalent generic version of Renvela (sevelamer carbonate) for oral suspension, approved by the U.S. Food and Drug Administration. The Renvela brand and generic had U.S. sales of approximately $101 million MAT